Stock Events

Stock Events

enGene Therapeutics (ENGN) Q4 2025 Earnings

22DecConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.73

-0.61

-0.49

-0.37

Details

Expected EPS

-0.566903

Actual EPS

-0.73

Surprise EPS

-0.16

Surprise Percent

+28.77%

Description

enGene Therapeutics (ENGN) has reported earnings of -0.73 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.